Showing results (201-210 of 397) with videos related to
Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancerM Markman, T Hakes, R Barakat, et al.Gynecologic Oncology|January 16, 1999
Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgiasM Markman, A Kennedy, K Webster, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Paclitaxel administration to gynecologic cancer patients with major cardiac risk factorsM Markman, A Kennedy, K Webster, et al.Gynecologic Oncology|October 24, 1998
Low-dose oral granisetron (1 mg) plus intravenous dexamethasone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapyM Markman, A Kennedy, K Webster, et al.The British Journal of Ophthalmology|February 1, 1983
Irreversible visual loss in Waldenström's macroglobulinaemiaE L Thomas, R J Olk, M Markman, et al.Gynecologic Oncology|June 30, 2000
The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapyM Markman, A Kennedy, K Webster, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancerM Markman, A Kennedy, K Webster, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneumM Markman, A Kennedy, K Webster, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1997
Low-dose intravenous ondansetron (8 mg) plus dexamethasone: an effective regimen for the control of carboplatin-induced emesisM Markman, A Kennedy, K Webster, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer CenterM Markman, A Kennedy, K Webster, et al.Pageof 40